Another 3 Common Pesticides Are Now Linked To Parkinson’s Disease Risk

Translate to Spanish or other 102 languages!

Three more pesticides commonly used in the United States have now been linked to heightened Parkinson’s risk. Image for illustration purposes
Three more pesticides commonly used in the United States have now been linked to heightened Parkinson’s risk. Image for illustration purposes
- Advertisement -
  • Parkinson’s disease prevalence is growing fast, and similar to some other neurological conditions, its causes are unclear. 
  • The potential impact of chemicals that are toxic to neurons in the part of the brain affected by Parkinson’s disease has been investigated since the 1980s. 
  • Despite this, many chemicals, particularly pesticides and herbicides that are known to pose a risk, are still used in many parts of the world. 
  • Researchers have now identified a risk of Parkinson’s disease associated with exposure to 14 pesticides. 

Parkinson’s disease is the fastest growingTrusted Source neurological disorder in the world at present, and the reason why is unclear.

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/another-3-common-pesticides-are-now-linked-to-parkinsons-disease-risk?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-03-11&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

AMA Unveils New Initiative to Boost Nutrition Education Nationwide

The American Medical Association (AMA) is launching a nutrition education initiative to equip physicians and medical students with practical, evidence-based knowledge and tools to help patients live healthier lives.

Study Finds GLP‑1 Therapy Reduces Heart and Kidney Risks for Type 1 Diabetes Patients

People with type 1 diabetes who took GLP-1 receptor agonist (GLP-1-RA) drugs for weight loss or better blood-sugar control had significantly reduced risks of major cardiovascular events and end-stage kidney disease without any increase in safety concerns, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

The Silent Toll of Substance Use on Today’s Young Adults

Mega Doctor News by University of Michigan Newswise - Young adults who heavily use substances...

New Study Identifies Hormone Linking Obesity to Pancreatic Cancer

Mega Doctor News by Yale School of Medicine Newswise — Obesity increases the body's need...
- Advertisement -